Segui
Maria Letizia Barreca
Maria Letizia Barreca
Department of Pharmaceutical Sciences - University of Perugia
Email verificata su unipg.it - Home page
Titolo
Citata da
Citata da
Anno
5-Arylidene-2-imino-4-thiazolidinones: design and synthesis of novel anti-inflammatory agents
R Ottana, R Maccari, ML Barreca, G Bruno, A Rotondo, A Rossi, ...
Bioorganic & medicinal chemistry 13 (13), 4243-4252, 2005
3892005
Discovery of 2, 3-diaryl-1, 3-thiazolidin-4-ones as potent anti-HIV-1 agents
ML Barreca, A Chimirri, L De Luca, AM Monforte, P Monforte, A Rao, ...
Bioorganic & medicinal chemistry letters 11 (13), 1793-1796, 2001
3202001
Design, synthesis, structure− activity relationships, and molecular modeling studies of 2, 3-diaryl-1, 3-thiazolidin-4-ones as potent anti-HIV agents
ML Barreca, J Balzarini, A Chimirri, ED Clercq, LD Luca, HD Hltje, ...
Journal of medicinal chemistry 45 (24), 5410-5413, 2002
2422002
Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors
ML Barreca, S Ferro, A Rao, L De Luca, M Zappal, AM Monforte, ...
Journal of medicinal chemistry 48 (22), 7084-7088, 2005
1802005
A 1, 8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replication
S Massari, D Daelemans, ML Barreca, A Knezevich, S Sabatini, ...
Journal of medicinal chemistry 53 (2), 641-648, 2010
1352010
Pharmacophore‐based discovery of small‐molecule inhibitors of protein–protein interactions between HIV‐1 integrase and cellular cofactor LEDGF/p75
L De Luca, ML Barreca, S Ferro, F Christ, N Iraci, R Gitto, AM Monforte, ...
ChemMedChem 4 (8), 1311-1316, 2009
1322009
Design, Synthesis, and Biological Evaluation of a Series of 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as Dual Inhibitors of Human Immunodeficiency Virus Type 1…
M Billamboz, F Bailly, ML Barreca, L De Luca, JF Mouscadet, C Calmels, ...
Journal of medicinal chemistry 51 (24), 7717-7730, 2008
1322008
Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: mechanism for inhibition and drug resistance
ML Barreca, KW Lee, A Chimirri, JM Briggs
Biophysical Journal 84 (3), 1450-1463, 2003
992003
Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist
R Gitto, ML Barreca, L De Luca, G De Sarro, G Ferreri, S Quartarone, ...
Journal of medicinal chemistry 46 (1), 197-200, 2003
992003
Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains
ML Barreca, A Rao, L De Luca, N Iraci, AM Monforte, G Maga, ...
Bioorganic & medicinal chemistry letters 17 (7), 1956-1960, 2007
862007
AMPA receptor antagonists as potential anticonvulsant drugs
GD Sarro, R Gitto, E Russo, GF Ibbadu, ML Barreca, LD Luca, A Chimirri
Current topics in medicinal chemistry 5 (1), 31-42, 2005
852005
Anti-HIV agents: design and discovery of new potent RT inhibitors
ML Barreca, A Chimirri, E De Clercq, L De Luca, AM Monforte, P Monforte, ...
Il Farmaco 58 (3), 259-263, 2003
852003
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs)
ML Barreca, A Carotti, A Carrieri, A Chimirri, AM Monforte, MP Calace, ...
Bioorganic & medicinal chemistry 7 (11), 2283-2292, 1999
841999
A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model
IL Shytaj, S Norelli, B Chirullo, A Della Corte, M Collins, J Yalley-Ogunro, ...
PLoS pathogens 8 (6), e1002774, 2012
802012
Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor
L De Luca, S Ferro, R Gitto, ML Barreca, S Agnello, F Christ, Z Debyser, ...
Bioorganic & medicinal chemistry 18 (21), 7515-7521, 2010
792010
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT
ML Barreca, A Rao, L De Luca, M Zappala, AM Monforte, G Maga, ...
Journal of Medicinal Chemistry 48 (9), 3433-3437, 2005
772005
Analysis of the full-length integrase–DNA complex by a modified approach for DNA docking
L De Luca, A Pedretti, G Vistoli, ML Barreca, L Villa, P Monforte, A Chimirri
Biochemical and Biophysical Research Communications 310 (4), 1083-1088, 2003
682003
Induced‐fit docking approach provides insight into the binding mode and mechanism of action of HIV‐1 integrase inhibitors
ML Barreca, N Iraci, L De Luca, A Chimirri
ChemMedChem: Chemistry Enabling Drug Discovery 4 (9), 1446-1456, 2009
622009
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors
ML Barreca, L De Luca, N Iraci, A Rao, S Ferro, G Maga, A Chimirri
Journal of Chemical Information and Modeling 47 (2), 557-562, 2007
592007
Efficient 3D database screening for novel HIV-1 IN inhibitors
ML Barreca, A Rao, L De Luca, M Zappal, C Gurnari, P Monforte, ...
Journal of chemical information and computer sciences 44 (4), 1450-1455, 2004
562004
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20